NCT06965062 - Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2030

Conditions

Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's TypeAlzheimer's DiseaseAlzheimer's Disease (AD)

Interventions

PROCEDURE

Deep cervical lymph node to venous bypass (DCLNV-BP)

Participants will under bilateral deep cervical lymph node to venous bypass procedure under general anaesthesia.

Trial Locations (1)

RECRUITING

Changi General Hospital, Singapore